The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial

Nadine Sperb1, Irina A Maksakova2, Leo Escano2

  • 1Department of Internal Medicine III, University Hospital Ulm, Ulm, 89081, Germany.

Leukemia
|March 18, 2025
PubMed

Insights

The miR-106a-363 cluster, especially miR-106a-5p, worsens acute myeloid leukemia (AML) by boosting mitochondrial function. This microRNA cluster promotes AML progression and poorer survival rates in patients.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Hematology

Background:

  • The miR-106a-363 cluster's role in adult acute myeloid leukemia (AML) is not fully understood.
  • MicroRNAs (miRNAs) are key regulators of gene expression implicated in various cancers.
  • Understanding specific miRNA roles is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the clinical and functional significance of the miR-106a-363 cluster in adult AML.
  • To determine the impact of this cluster on leukemogenesis and patient survival.
  • To elucidate the molecular mechanisms, particularly mitochondrial pathways, affected by the cluster.

Main Methods:

  • Analysis of The Cancer Genome Atlas (TCGA) LAML miRNA sequencing data.
  • Overexpression studies in a murine AML model.
  • Proteomics analysis of leukemic bone marrow cells.
  • High-resolution respirometry and STED microscopy.

Main Results:

  • High expression of miR-106a-363 cluster members correlated with inferior survival in AML patients.
  • miR-106a-5p and miR-20b-5p were elevated in adverse-risk AML.
  • Overexpression accelerated leukemogenesis in a murine model, linked to mitochondrial dysfunction.
  • miR-106a-5p enhanced mitochondrial respiration and volume.

Conclusions:

  • The miR-106a-363 cluster, particularly miR-106a-5p, promotes AML progression.
  • Modulation of mitochondrial function is a key mechanism by which this cluster increases leukemogenicity.
  • These findings highlight the miR-106a-363 cluster as a potential therapeutic target in AML.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.1K